BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Personalized medicine
,
Fluoxetine
,
rs2300478
,
SNCA
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Fgfr4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Microbial culture finding
Stachybotryotoxicosis
Fragile X syndrome
11p partial monosomy syndrome
Severe acute respiratory syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Sox2 protein, zebrafish
IL7 protein, human
acetylsalicylsalicylic acid
isocorydine
Cyclacillin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SLC39A8
TCF21
PAX3
INHA
PSEN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Liver-specific FGFR4 knockdown in mice on an HFD increases bile acid synthesis and improves hepatic …
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of…
Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.
FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metas…
Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression
FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanc…
Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Foll…
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular C…
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ